GB201906804D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB201906804D0 GB201906804D0 GBGB1906804.8A GB201906804A GB201906804D0 GB 201906804 D0 GB201906804 D0 GB 201906804D0 GB 201906804 A GB201906804 A GB 201906804A GB 201906804 D0 GB201906804 D0 GB 201906804D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1906804.8A GB201906804D0 (en) | 2019-05-14 | 2019-05-14 | Therapeutic agents |
| PCT/EP2020/063083 WO2020229427A1 (en) | 2019-05-14 | 2020-05-11 | Antimalarial hexahydropyrimidine analogues |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1906804.8A GB201906804D0 (en) | 2019-05-14 | 2019-05-14 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201906804D0 true GB201906804D0 (en) | 2019-06-26 |
Family
ID=67384656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1906804.8A Ceased GB201906804D0 (en) | 2019-05-14 | 2019-05-14 | Therapeutic agents |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201906804D0 (en) |
| WO (1) | WO2020229427A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021026884A1 (en) * | 2019-08-15 | 2021-02-18 | Merck Sharp & Dohme Corp. | Antimalarial agents |
| GB202010606D0 (en) | 2020-07-10 | 2020-08-26 | Ucb Biopharma Sprl | Therapeutic agents |
| JP2025505665A (en) | 2022-02-08 | 2025-02-28 | ユーシービー バイオファルマ エスアールエル | Antimalarial hexahydropyrimidine analogues |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| EP2153832B1 (en) | 2003-12-15 | 2016-03-09 | Merck Sharp & Dohme Corp. | Heterocyclic aspartyl protease inhibitors |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (en) | 2009-10-08 | 2015-04-27 | IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS | |
| WO2016118404A1 (en) | 2015-01-20 | 2016-07-28 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use |
| AU2016250519A1 (en) | 2015-04-21 | 2017-11-30 | Allgenesis Biotherapeutics, Inc. | Compounds and their use as BACE1 inhibitors |
| US11136310B2 (en) | 2015-11-25 | 2021-10-05 | UCB Biopharma SRL | Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors |
| EP3416647A4 (en) | 2016-02-18 | 2019-10-23 | Merck Sharp & Dohme Corp. | N3-SUBSTITUTED IMINOPYRIMIDINONES AS ANTIMALARIAL AGENTS |
| GB201603104D0 (en) | 2016-02-23 | 2016-04-06 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201805816D0 (en) | 2018-04-06 | 2018-05-23 | Ucb Biopharma Sprl | Therapeutic agents |
-
2019
- 2019-05-14 GB GBGB1906804.8A patent/GB201906804D0/en not_active Ceased
-
2020
- 2020-05-11 WO PCT/EP2020/063083 patent/WO2020229427A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020229427A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201909190D0 (en) | Therapeutic agents | |
| GB201909191D0 (en) | Therapeutic agents | |
| GB201909194D0 (en) | Therapeutic agents | |
| GB201820166D0 (en) | Therapeutic agents | |
| GB201820165D0 (en) | Therapeutic agents | |
| GB201902277D0 (en) | Therapeutic agents | |
| GB201900702D0 (en) | Therapy | |
| GB201805816D0 (en) | Therapeutic agents | |
| ZA202200731B (en) | Combination therapy | |
| GB201906804D0 (en) | Therapeutic agents | |
| IL288237A (en) | Combination therapy | |
| GB201909493D0 (en) | Therapeutic interactions | |
| GB201914006D0 (en) | Combination Therapy | |
| GB201910473D0 (en) | Combination therapy | |
| GB201906864D0 (en) | Combination therapy | |
| GB201913759D0 (en) | Therapeutic agents | |
| GB201911865D0 (en) | Therapeutic agents | |
| GB201911712D0 (en) | Therapeutic agents | |
| GB201820172D0 (en) | Therapeutic agents | |
| GB201820168D0 (en) | Therapeutic agents | |
| GB201820164D0 (en) | Therapeutic agents | |
| GB201820162D0 (en) | Therapeutic agents | |
| GB201820160D0 (en) | Therapeutic agents | |
| GB201820170D0 (en) | Therapeutic agents | |
| GB201811753D0 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |